导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.03% | 1290/4773 |
| 近一周 | -2.45% | 2204/5462 |
| 近一月 | -4.61% | 2594/5421 |
| 近一季 | -8.00% | 2629/5209 |
| 近半年 | -5.24% | 2796/4920 |
| 近一年 | 9.86% | 1054/4366 |
| 近两年 | 76.32% | 859/2954 |
| 近三年 | 40.69% | 705/2253 |
| 成立以来 | 54.86% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.99% 1106/4961 |
18.88% 1338/5312 |
- - |
- - |
| 2025 | 31.86% 1211/4813 |
2.01% 1494/3635 |
1.91% 2030/4076 |
24.62% 1447/4524 |
1.79% 1215/4813 |
| 2024 | 7.76% 1622/3463 |
-2.78% 1430/2808 |
-5.18% 1663/3014 |
15.19% 1794/3129 |
1.47% 1066/3463 |
| 2023 | -6.59% 860/2656 |
7.17% 594/2280 |
-4.16% 1075/2385 |
-4.69% 1202/2515 |
-4.59% 1109/2655 |
| 2022 | -18.46% 712/2207 |
-13.38% 746/1919 |
2.58% 1283/2016 |
-10.46% 405/2113 |
2.48% 924/2208 |
| 2021 | 14.85% 320/1822 |
-1.68% 530/1255 |
8.88% 603/1330 |
4.09% 381/1466 |
3.08% 476/1822 |
| 2020 | - - |
- - |
15.45% 501/1067 |
6.24% 863/1164 |
2.55% 982/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 工银中证500ETF联接C VS. 长安沪深300非周期A(740101) |